PIRS - Pieris Pharmaceuticals, Inc. Quarterly EPS earnings growth

Symbol and logo of brand Pieris Pharmaceuticals (PIRS)

The current quarterly EPS trend on the GURU.Markets chart, where the -65.40 mark characterizes this parameter, complements data on the development of respiratory and oncology drugs through partnerships. The biotech business of Pieris Pharmaceuticals (PIRS) in the US and Germany relies on the Anticalin platform to combat cancer. However, the dissolution of alliances with industry behemoths has triggered a financial crisis and the threat of halting research.

Pieris Pharmaceuticals, Inc. (PIRS) Year-over-year earnings per one share growth for the last 12 months: for the period 07/04/2022 - 11/15/2026

Summary analytical data breakdowns for Pieris Pharmaceuticals (PIRS)

- share price and expert price forecast:
Comprehensive company analysis:Pieris Pharmaceuticals
Flagship merchandise of Pieris Pharma

As a manager, I view this indicator as a tool for assessing the rate of change in net earnings per share, where daily volatility reflects the struggle of market forces to revalue future cash flows. By analyzing the quarterly EPS trend profile, an investor can see how Pieris Pharmaceuticals (PIRS) leverages its scientific authority in anti-kallikrein development to convert oncology partnerships into financial results.

Who Pieris Pharmaceuticals competes with

HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|liquidia.com - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MNKD|AMPH (Amphastar) - Quarterly EPS earnings growth|Pacira Corp (PCRX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|Quarterly EPS earnings growth Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SCPH|Tectonic Therapeutic Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TNXP|SXTC (China SXT Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Eupraxia Pharmaceuticals (EPRX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months BioHarvest Sciences, Inc.|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORMP|ENTX - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months MindWalk Holdings, Inc. HYFT|Quarterly EPS earnings growth abvcpharma.com ABVC|CPIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months QNTM|FGEN (FibroGen Corporation) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months Telomir Pharma|Year-over-year net earnings per share growth for the last 12 months RANI|Earnings per share growth in annualized terms for the last twelve months synergychc.com SNYR|Year-over-year earnings per share growth for the last twelve months Rallybio Corp (RLYB)|LEXX - Earnings per share growth in annualized terms for the last twelve months|Pulmatrix Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PTHL|Aptorum Group Ltd - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Lyra Therapeutics LYRA|IBO: Quarterly EPS earnings growth|TNFA (TNF Pharma) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months cbdmd.com|Year-over-year earnings per share growth for the last 12 months PRFX (PainReform Corp)|Quarterly EPS earnings growth CYTO|Year-over-year net earnings per share growth for the last 12 months Lipella Pharmaceuticals LIPO|Year-over-year earnings per share growth for the last twelve months OptiNose OPTN|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)